Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

21 May 2022: Clinical Research

Curative Analysis of Patients with Hepatocellular Carcinoma Using Transcatheter Arterial Chemoembolization Combined with Radiofrequency Ablation

Yifan Li AE , Diwen Zhu BCD , Weixin Ren AE* , Junpeng Gu BCD , Weizheng Ji BCD , Haixiao Zhang BCD , Yingjun Bao BCD , Gengfei Cao BCD , Asihaer Hasimu BCD

DOI: 10.12659/MSM.936246

Med Sci Monit 2022; 28:e936246

Supplementary Table 1 Comparison between groups before and after data imputation.

VariablesAfter (n=142)Before (n=142)StatisticsP
AFP, ng/ml, M (Q, Q)14.35 (4.40, 235.00)14.35 (4.55, 203.80)Z=0.3650.715
Tbil, μmol/L, M (Q, Q)16.50 (10.90, 20.80)16.50 (10.90, 20.80)Z=−0.0450.964
Albumin, U/L, Mean±SD38.55±6.0738.47±6.03t=0.100.919
ALT U/L, M (Q, Q)25.36 (18.20, 39.69)26.02 (18.30, 39.69)Z=0.1020.918
AST U/L, M (Q, Q)30.60 (22.85, 42.50)30.50 (22.85, 40.90)Z=−0.0880.930
LDH, U/L, Mean±SD189.82±41.75189.80±43.16t=0.000.996
ALP, U/L, M (Q, Q)91.50 (70.00, 126.00)92.00 (71.00, 126.00)Z=0.1640.870
AFP – alpha-fetoprotein; Tbil – total bilirubin; ALT – alanine transaminase; AST – aspartate transaminase; LDH – lactic dehydrogenase; ALP – alkaline phosphatase.

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750